Original Research

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Hou H, Sun D, Liu K, Jiang M, Liu D, Zhu J, Zhou N, Cong J, Zhang X

Cancer Management and Research 2019, 11:4109-4118

Published Date: 7 May 2019